骨形成促进剂及其他防治骨质疏松症药物研究进展

被引：6

作者：

王保平

朱梅

机构：

[1] 天津医科大学总医院内分泌科

来源：

中国临床医生 | 2013年 / 41卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R983 [泌尿科药物];

学科分类号：

100705 [微生物与生化药学];

摘要：

<正>骨质疏松症(osteoporosis,OP)是一种全身性骨病,以骨强度下降、骨折风险增加为特征。目前抗OP治疗药物主要有3类,一是促进骨矿化的药物,如维生素D及钙制剂等;二是抑制骨吸收的药物,如双膦酸盐、降钙素、雌激素类等;三是促进骨形成的药物,主要

引用

页码：11 / 13

页数：3

共 10 条

[1]

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation [J].

Manuel Fernandez, Juan ;

Silvina Molinuevo, Maria ;

Sedlinsky, Claudia ;

Schurman, Leon ;

Maria Cortizo, Ana ;

Desmond McCarthy, Antonio .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 706 (1-3) :41-47

[2]

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men [J].

Kaufman, J. -M. ;

Audran, M. ;

Bianchi, G. ;

Braga, V. ;

Diaz-Curiel, M. ;

Francis, R. M. ;

Goemaere, S. ;

Josse, R. ;

Palacios, S. ;

Ringe, J. D. ;

Felsenberg, D. ;

Boonen, S. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) :592-601

[3]

Safety of Osteoanabolic Therapy: A Decade of Experience [J].

Capriani, Cristiana ;

Irani, Dinaz ;

Bilezikian, John P. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (12) :2419-2428

[4]

Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [J].

Baron, Roland ;

Hesse, Eric .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :311-325

[5]

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis [J].

Finkelstein, Joel S. ;

Wyland, Jason J. ;

Lee, Hang ;

Neer, Robert M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04) :1838-1845

[6]

Effects of combination treatment with alendronate and vitamin K2 on bone mineral density and strength in ovariectomized mice [J].

Sasaki, Hiroshi ;

Miyakoshi, Naohisa ;

Kasukawa, Yuji ;

Maekawa, Shigeto ;

Noguchi, Hideaki ;

Kamo, Keji ;

Shimada, Yoichi .

JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (04) :403-409

[7]

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy [J].

Glover, Sarah J. ;

Eastell, Richard ;

McCloskey, Eugene V. ;

Rogers, Angela ;

Garnero, Patrick ;

Lowery, Jonathan ;

Belleli, Rossella ;

Wright, Timothy M. ;

John, Markus R. .

BONE, 2009, 45 (06) :1053-1058

[8]

Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis [J].

Hatzigeorgiou, C ;

Jackson, JL .

OSTEOPOROSIS INTERNATIONAL, 2005, 16 (08) :990-998

[9]

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy [J].

Kaufman, JM ;

Orwoll, E ;

Goemaere, S ;

San Martin, J ;

Hossain, A ;

Dalsky, GP ;

Lindsay, R ;

Mitlak, BH .

OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) :510-516

[10]

他汀类药物抗骨质疏松作用的实验研究进展 [J].

田发明 ;

张柳 .

中国骨质疏松杂志, 2007, (05) :371-375

← 1 →